Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Functional fragrances gain traction in Indonesia amidst rising mental health awareness, finds GlobalData

Indonesia is witnessing a notable shift towards functional fragrances as consumer preferences evolve. These fragrances, marketed for their mood-enhancing and wellness properties, are gaining traction amidst growing awareness about mental health and increased stress levels. With an emphasis on overall well-being, fragrance manufacturers are introducing innovative variants, such as Kahf’s Revered Oud and The Body […]
Read more
,

Apple cautious AI approach hints focus on user privacy and security, says GlobalData

Apple Inc is strategically advancing its position in the artificial intelligence (AI) domain, signifying a pivotal shift in the company’s approach to integrate AI into its core operations and product ecosystem. The recent innovations and acquisitions underscore the Cupertino-based tech giant’s focus on bringing AI to its offerings while prioritizing user privacy and ethical AI, […]
Read more

TikTok is not the problem, its privacy, says GlobalData

As the US Congress deliberates actions against TikTok, a wider discourse on data privacy and sales comes to the forefront. The discussion extends beyond TikTok’s fate, encompassing broader concerns regarding data usage and its implications. With growing scrutiny over data brokerage practices and privacy, there is a pressing need for regulatory measures to safeguard consumer […]
Read more
,

Blockchain industry primed for $291 billion revenue by 2030 driven by asset tokenization, says GlobalData

The blockchain industry, although volatile and nascent, has made significant progress in a short span of time, driven by remarkable innovation. Global blockchain platform and services revenue is set to grow from $12 billion in 2023 to $291 billion in 2030.  This growth trajectory reflects a more delineated and specialized expenditure pattern, with specific areas […]
Read more
,

Evolving blockchain technology can transform diverse oil and gas applications, says GlobalData

Blockchain is emerging as a technology that demands attention within the oil and gas sector. It presents novel approaches to service contracts, review pricing, and support the entirety of the transaction life cycle. It thus promises potential cost reductions and enhanced process efficiencies. Moreover, the advantages of blockchain in the oil and gas industry manifest […]
Read more

Inspire revenue surge signals neuromodulation takeover in obstructive sleep apnea treatment, says GlobalData

Neuromodulation is rapidly redefining the therapeutic landscape for obstructive sleep apnea (OSA), with Inspire Medical Systems at the forefront, showcasing an impressive revenue climb from $233 million in 2021 to $624 million in 2023. This growth not only demonstrates the efficacy and demand for hypoglossal neuromodulation but also highlights the significant potential within this market […]
Read more
,

Germany VC landscape thrives despite volume decline, signals growth potential, says GlobalData

Germany’s venture capital (VC) landscape saw notable activity during January-February 2024, with 62 disclosed deals of worth $1.3 billion. Despite a 38.6% year-on-year (YoY) decline in deal volume, the funding value witnessed an impressive 18.9% growth, positioning the country among the top five global markets by funding value. Significant VC funding, including those secured by […]
Read more
,

Patent filings signal steady upward trajectory in intra-operative surgical guidance landscape, reveals GlobalData

Philips’ new LumiGuide, powered by fiber optic real shape (FORS) technology, enables X-ray radiation-free minimally invasive surgery, marking a significant advancement in intra-operative surgical guidance. Though still in its nascent stages, the landscape of innovation as captured through patent filings is showing a consistent upward trajectory. This is especially evident with corporations filing an increased […]
Read more

GlobalData sheds light on colorectal cancer awareness and prevention

March is Colorectal Cancer (CRC) Awareness Month and it highlights a disease that affects millions worldwide. Throughout March, individuals, healthcare professionals, and organizations join forces to raise awareness about the importance of early detection through screening and implementing preventative measures. As younger demographics face rising incidence of CRC over the next two decades, they must […]
Read more

Alternative payments account for over two thirds of total e-commerce payments in China, reveals GlobalData

Alternative payment methods such as mobile and digital wallets dominate the e-commerce space in China. They have displaced cash and cards and are the most preferred payment method with 67.3% market share in 2023, finds GlobalData, a leading data and analytics company. GlobalData’s E-Commerce Analytics reveals that Chinese e-commerce market is expected to register a […]
Read more
,

UK startup ecosystem stays globally prominent despite YoY dip in first two months of 2024, reveals GlobalData

Amidst a decline in year-on-year (YoY) startup venture capital (VC) funding, the UK’s entrepreneurial ecosystem remains resilient, retaining its influential position globally despite market fluctuations. With $1.4 billion raised across 152 deals in the first two months of 2024, the UK sustains its prominence in Europe’s venture capital landscape, showcasing adaptability and enduring appeal amidst […]
Read more

Global digital twins market will surpass $150 billion in 2030, forecasts GlobalData

Digital twins are becoming increasingly integral as companies prioritize resilience and digital transformation in their operations. They serve as virtual replicas, enhancing operational efficiency, cost reduction, and predictive analytics, while enabling remote collaboration. With advancements in IoT, cloud, AI, and data analytics, the global market for digital twins, spanning software and services, is projected to […]
Read more

Pfizer’s Braftovi to command 42% share of BRAF inhibitors melanoma market by 2028, forecasts GlobalData

Since Roche‘s Zelboraf gained (vemurafenib) FDA approval in 2011, significant strides have been made in BRAF-targeted cancer therapies, underscoring the significance of combating BRAF mutations in melanoma. Against this backdrop, Pfizer‘s Braftovi (encorafenib) is positioned to secure a dominant 42% share of the BRAF inhibitors market for melanoma by 2028, underscoring its pivotal role in […]
Read more
1 … 70 71 72 73 74 … 209